help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermansen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermansen, K.

Endocrinology, Vol 113, 1149-1154, Copyright © 1983 by Endocrine Society

ARTICLES

Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro

K Hermansen

Enkephalins are naturally occurring peptides with powerful opiate-like effects which have recently been found in nerves of the pancreas. To assess the nature and extent of the influence that opiates exert on the endocrine pancreas, we examined the effects of MET-enkephalin (MEK), leu-enkephalin, morphine, and the opiate antagonist naloxone (NAL) as well as adrenergic and cholinergic blockade on the hormone release from the isolated perfused dog pancreas. It was found that MEK (1-100 nM) dose dependently inhibited somatostatin release and stimulated insulin secretion. The effects of MEK (100 nM) were modulated by the prevailing glucose concentration. Thus, more pronounced changes in D and B cell release were obtained at high (11 mM) rather than at low (1.3 mM) glucose. Ten micromolar of morphine inhibited somatostatin and stimulated insulin secretion, effects being antagonized by NAL (10 microM). NAL (10 microM) similarly counteracted the MEK (50 nM)-induced pertubations in islet hormone secretion. NAL (10 microM) per se did not affect somatostatin or insulin secretion at 8.3 mM glucose. Infusions of either 1 microM phentolamine, 1 microM propranolol, or 1 microM atropine did not significantly alter the amount of somatostatin or insulin secretion during the infusion of 50 nM MEK. In conclusion, the results are suggestive of enkephalins reaching the islets by neural pathways and directly modifying islet hormone secretion by directly interacting with opiate receptors on the islet cells.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
P. Gilon and J.-C. Henquin
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function
Endocr. Rev., October 1, 2001; 22(5): 565 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. P. Li, K. Y. Lee, T.-M. Chang, and W. Y. Chey
MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin
Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G890 - G896.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society